Patients at risk for HBV infection should be evaluated for prior evidence of HBV infection before initiating Enbrel therapy.
B- hepatiidi viiruse nakkuse ohuga patsiente tuleb enne ravi alustamist Enbreliga hinnata B- hepatiidi viiruse nakkuse tunnuste suhtes.